Stratos Wealth Partners, Ltd. Biogen Inc. Transaction History

Stratos Wealth Partners, Ltd.

$6.79 Billion
Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 3,196 shares of BIIB stock, worth $489,850. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,196

Previous 3,495 8.56%

Holding current value

$489,850

Previous $810,000 23.58%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$189.07 - $236.8 $56,531 - $70,803	-299 Reduced 8.56%	3,196 $619,000
Q2 2024 Jul 24, 2024	SELL	$190.52 - $236.72 $5,525 - $6,864	-29 Reduced 0.82%	3,495 $810,000
Q1 2024 Apr 16, 2024	SELL	$212.02 - $267.71 $105,797 - $133,587	-499 Reduced 12.4%	3,524 $759,000
Q4 2023 Jan 24, 2024	SELL	$222.59 - $267.94 $2,003 - $2,411	-9 Reduced 0.22%	4,023 $1.04 Million
Q3 2023 Oct 24, 2023	BUY	$253.3 - $285.89 $10,638 - $12,007	42 Added 1.05%	4,032 $1.04 Million
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $5,505 - $6,361	-20 Reduced 0.5%	3,990 $1.14 Million
Q1 2023 Apr 27, 2023	SELL	$256.56 - $292.34 $167,533 - $190,898	-653 Reduced 14.0%	4,010 $1.11 Million
Q4 2022 Jan 19, 2023	SELL	$252.44 - $306.72 $19,185 - $23,310	-76 Reduced 1.6%	4,663 $0
Q3 2022 Oct 24, 2022	SELL	$194.69 - $268.46 $16,548 - $22,819	-85 Reduced 1.76%	4,739 $1.27 Million
Q2 2022 Jul 22, 2022	BUY	$187.54 - $223.02 $254,679 - $302,861	1,358 Added 39.18%	4,824 $984,000
Q1 2022 Apr 26, 2022	SELL	$193.77 - $244.14 $68,788 - $86,669	-355 Reduced 9.29%	3,466 $730,000
Q4 2021 Jan 14, 2022	SELL	$223.92 - $287.77 $64,488 - $82,877	-288 Reduced 7.01%	3,821 $917,000
Q3 2021 Oct 19, 2021	SELL	$282.99 - $369.05 $30,279 - $39,488	-107 Reduced 2.54%	4,109 $1.16 Million
Q2 2021 Jul 19, 2021	BUY	$259.0 - $414.71 $50,505 - $80,868	195 Added 4.85%	4,216 $1.46 Million
Q1 2021 Apr 27, 2021	SELL	$242.95 - $284.63 $68,997 - $80,834	-284 Reduced 6.6%	4,021 $1.13 Million
Q4 2020 Jan 29, 2021	SELL	$236.26 - $355.63 $119,075 - $179,237	-504 Reduced 10.48%	4,305 $1.05 Million
Q3 2020 Oct 29, 2020	SELL	$264.77 - $305.71 $236,969 - $273,610	-895 Reduced 15.69%	4,809 $1.36 Million
Q2 2020 Jul 28, 2020	SELL	$258.66 - $342.55 $298,493 - $395,302	-1,154 Reduced 16.83%	5,704 $1.53 Million
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $133,618 - $169,496	-497 Reduced 6.76%	6,858 $2.17 Million
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $41,591 - $57,469	-189 Reduced 2.51%	7,355 $2.18 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1.59 Million - $1.78 Million	7,299 Added 2979.18%	7,544 $1.76 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $1.59 Million - $1.79 Million	-7,321 Reduced 96.76%	245 $2.1 Million
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $21,271 - $23,446	-97 Reduced 1.27%	7,566 $1.77 Million
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $89,067 - $139,312	-411 Reduced 5.09%	7,663 $1.81 Million
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $93,019 - $117,818	-334 Reduced 3.97%	8,074 $2.43 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $33,753 - $44,140	-115 Reduced 1.35%	8,408 $2.97 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $110,218 - $131,357	-428 Reduced 4.78%	8,523 $2.47 Million
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $23,151 - $32,743	-89 Reduced 0.98%	8,951 $2.45 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $50,145 - $56,166	163 Added 1.84%	9,040 $2.88 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $2.5 Million - $2.93 Million	8,877	8,877 $2.78 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Biogen Inc. Transaction History